Since the intrinsic modulators that contribute to ALOX12 activation remain largely unknown, a designed ALOX12 activator becomes indispensable and hence holds great promise to promote ACSL4-independent ferroptosis of cancer cells. The gene discussed is ACSL4; the disease is cancer.